The multifaceted role of cytochrome P450-Derived arachidonic acid metabolites in diabetes and diabetic cardiomyopathy

References

• Abou Salem RB. 2015. Cardiac fibroblast injury in diabetes: new insights on the role of cytochromes p450.
   Google Scholar
• American Diabetes Association. 2004. Diagnosis and classification of diabetes mellitus. Diabetes Care. 27(Suppl 1):s5–s10.
   PubMedGoogle Scholar
• Anderson EJ, Lustig ME, Boyle KE, Woodlief TL, Kane DA, Lin C-T, Price JW, III, Kang L, Rabinovitch PS, Szeto HH, et al. 2009. Mitochondrial h2o2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin Invest. 119(3):573–581.
   PubMed Web of Science ®Google Scholar
• Aragno M, Mastrocola R, Medana C, Catalano MG, Vercellinatto I, Danni O, Boccuzzi G. 2006. Oxidative stress-dependent impairment of cardiac-specific transcription factors in experimental diabetes. Endocrinology. 147(12):5967–5974.
   PubMed Web of Science ®Google Scholar
• Bauersachs J, Popp R, Hecker M, Sauer E, Fleming I, Busse R. 1996. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation. 94(12):3341–3347.
   PubMed Web of Science ®Google Scholar
• Benoit C, Renaudon B, Salvail D, Rousseau E. 2001. Eets relax airway smooth muscle via an epdhf effect: BK(Ca) channel activation and hyperpolarization. Am J Physiol Lung Cell Mol Physiol. 280(5):L965–L973.
   PubMed Web of Science ®Google Scholar
• Berry C, Hamilton CA, Brosnan MJ, Magill FG, Berg GA, McMurray JJ, Dominiczak AF. 2000. Investigation into the sources of superoxide in human blood vessels: Angiotensin ii increases superoxide production in human internal mammary arteries. Circulation. 101(18):2206–2212.
   PubMed Web of Science ®Google Scholar
• Bleich D, Chen S, Zipser B, Sun D, Funk CD, Nadler JL. 1999. Resistance to type 1 diabetes induction in 12-lipoxygenase knockout mice. J Clin Invest. 103(10):1431–1436.
   PubMed Web of Science ®Google Scholar
• Bonnard C, Durand A, Peyrol S, Chanseaume E, Chauvin M-A, Morio B, Vidal H, Rieusset J. 2008. Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. J Clin Invest. 118(2):789–800.
   PubMed Web of Science ®Google Scholar
• Boudina S, Abel ED. 2007. Diabetic cardiomyopathy revisited. Circulation. 115(25):3213–3223.
   PubMed Web of Science ®Google Scholar
• Boudina S, Bugger H, Sena S, O'Neill BT, Zaha VG, Ilkun O, Wright JJ, Mazumder PK, Palfreyman E, Tidwell TJ, et al. 2009. Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart. Circulation. 119(9):1272–1283.
   PubMed Web of Science ®Google Scholar
• Brash AR. 2001. Arachidonic acid as a bioactive molecule. J Clin Invest. 107(11):1339–1345.
   PubMed Web of Science ®Google Scholar
• Brownlee M. 2001. Biochemistry and molecular cell biology of diabetic complications. Nature. 414(6865):813–820.
   PubMed Web of Science ®Google Scholar
• Buczynski MW, Dumlao DS, Dennis EA. 2009. Thematic review series: Proteomics. An integrated omics analysis of eicosanoid biology. J Lipid Res. 50(6):1015–1038.
   PubMed Web of Science ®Google Scholar
• Bugger H, Abel ED. 2014. Molecular mechanisms of diabetic cardiomyopathy. Diabetologia. 57(4):660–671.
   PubMed Web of Science ®Google Scholar
• Burke JE, Dennis EA. 2009. Phospholipase a2 structure/function, mechanism, and signaling. J Lipid Res. 50(Suppl):S237–S242.
   PubMed Web of Science ®Google Scholar
• Burke MA, Mutharasan RK, Ardehali H. 2008. The sulfonylurea receptor, an atypical atp-binding cassette protein, and its regulation of the katp channel. Circ Res. 102(2):164–176.
   PubMed Web of Science ®Google Scholar
• Cai L, Kang YJ. 2001. Oxidative stress and diabetic cardiomyopathy. Cardiovasc Toxicol. 1(3):181–193.
   PubMedGoogle Scholar
• Cai L, Li W, Wang G, Guo L, Jiang Y, Kang YJ. 2002. Hyperglycemia-induced apoptosis in mouse myocardium: Mitochondrial cytochrome c-mediated caspase-3 activation pathway. Diabetes. 51(6):1938–1948.
   PubMed Web of Science ®Google Scholar
• Campbell WB, Gebremedhin D, Pratt PF, Harder DR. 1996. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res. 78(3):415–423.
   PubMed Web of Science ®Google Scholar
• Campbell WB, Harder DR. 1999. Endothelium-derived hyperpolarizing factors and vascular cytochrome p450 metabolites of arachidonic acid in the regulation of tone. Circ Res. 84(4):484–488.
   PubMed Web of Science ®Google Scholar
• Capozzi ME, Suarez S, Penn JS. 2014. The role of cytochrome p450 epoxygenases and their epoxyeicosatrienoic acid products in diabetes-induced retinal inflammation. Invest Ophthalmol Visual Sci. 55(13):5838–5838.
   Web of Science ®Google Scholar
• Carroll MA, Balazy M, Margiotta P, Huang DD, Falck JR, McGiff JC. 1996. Cytochrome p-450-dependent hetes: Profile of biological activity and stimulation by vasoactive peptides. Am J Physiol Regulat Integrat Compar Physiol. 271(4):R863–R869.
   Web of Science ®Google Scholar
• Carvalho LSF, Benseñor IM, Nogueira ACC, Duncan BB, Schmidt MI, Blaha MJ, Toth PP, Jones SR, Santos RD, Lotufo PA, on behalf of the ELSA-Brasil study, et al. 2021. Increased particle size of triacylglycerol-enriched remnant lipoproteins, but not their plasma concentration or lipid content, augments risk prediction of incident type 2 diabetes. Diabetologia. 64(2):385–396.
   PubMed Web of Science ®Google Scholar
• Casis O, Echevarria E. 2004. Diabetic cardiomyopathy: Electromechanical cellular alterations. Curr Vasc Pharmacol. 2(3):237–248.
   PubMedGoogle Scholar
• Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. 1994. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care. 17(9):961–969.
   PubMed Web of Science ®Google Scholar
• Chawla A, Chawla R, Jaggi S. 2016. Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum? Indian. Indian J Endocrinol Metab. 20(4):546–551.
   PubMedGoogle Scholar
• Chen D, Whitcomb R, MacIntyre E, Tran V, Do ZN, Sabry J, Patel DV, Anandan SK, Gless R, Webb HK. 2012. Pharmacokinetics and pharmacodynamics of ar9281, an inhibitor of soluble epoxide hydrolase, in single- and multiple-dose studies in healthy human subjects. J Clin Pharmacol. 52(3):319–328.
   PubMed Web of Science ®Google Scholar
• Chen H, Chen G, Zheng X, Guo Y. 2019. Contribution of specific diseases and injuries to changes in health adjusted life expectancy in 187 countries from 1990 to 2013: Retrospective observational study. BMJ. 364:l969.
   PubMed Web of Science ®Google Scholar
• Chen JK, Capdevila J, Harris RC. 2001. Cytochrome p450 epoxygenase metabolism of arachidonic acid inhibits apoptosis. Mol Cell Biol. 21(18):6322–6331.
   PubMed Web of Science ®Google Scholar
• Chen L, Fan C, Zhang Y, Bakri M, Dong H, Morisseau C, Maddipati KR, Luo P, Wang CY, Hammock BD, et al. 2013. Beneficial effects of inhibition of soluble epoxide hydrolase on glucose homeostasis and islet damage in a streptozotocin-induced diabetic mouse model. Prostaglandins Other Lipid Mediat. 104-105:42–48.
   PubMed Web of Science ®Google Scholar
• Chen M, Yang ZD, Smith KM, Carter JD, Nadler JL. 2005. Activation of 12-lipoxygenase in proinflammatory cytokine-mediated beta cell toxicity. Diabetologia. 48(3):486–495.
   PubMed Web of Science ®Google Scholar
• Chen Y, Hua Y, Li X, Arslan IM, Zhang W, Meng G. 2020. Distinct types of cell death and the implication in diabetic cardiomyopathy. Front Pharmacol. 11:42.
   PubMed Web of Science ®Google Scholar
• Chen Y, Saari JT, Kang YJ. 1994. Weak antioxidant defenses make the heart a target for damage in copper-deficient rats. Free Radic Biol Med. 17(6):529–536.
   PubMed Web of Science ®Google Scholar
• Chen YJ, Li J, Quilley J. 2008. Deficient renal 20-hete release in the diabetic rat is not the result of oxidative stress. Am J Physiol Heart Circ Physiol. 294(5):H2305–2312.
   PubMed Web of Science ®Google Scholar
• Chiang PC, Ran Y, Chou KJ, Cui Y, Wong H. 2011. Investigation of utilization of nanosuspension formulation to enhance exposure of 1,3-dicyclohexylurea in rats: Preparation for pk/pd study via subcutaneous route of nanosuspension drug delivery. Nanoscale Res Lett. 6(1):413.
   PubMed Web of Science ®Google Scholar
• Chowdhry MF, Vohra HA, Galiñanes M. 2007. Diabetes increases apoptosis and necrosis in both ischemic and nonischemic human myocardium: Role of caspases and poly-adenosine diphosphate-ribose polymerase. J Thorac Cardiovasc Surg. 134(1):124–131. 131.e121-123.
   PubMed Web of Science ®Google Scholar
• Connolly JM, Rose DP. 1998. Enhanced angiogenesis and growth of 12-lipoxygenase gene-transfected mcf-7 human breast cancer cells in athymic nude mice. Cancer Lett. 132(1-2):107–112.
   PubMed Web of Science ®Google Scholar
• Dai M, Wu L, Wang P, Wen Z, Xu X, Wang DW. 2017. Cyp2j2 and its metabolites eets attenuate insulin resistance via regulating macrophage polarization in adipose tissue. Sci Rep. 7(1):46743.
   PubMed Web of Science ®Google Scholar
• Das UN. 2006. Essential fatty acids: Biochemistry, physiology and pathology. Biotechnol J. 1(4):420–439.
   PubMedGoogle Scholar
• Das UN. 2018. Arachidonic acid in health and disease with focus on hypertension and diabetes mellitus: A review. J Adv Res. 11:43–55.
   PubMed Web of Science ®Google Scholar
• De Jong KA, Czeczor JK, Sithara S, McEwen K, Lopaschuk GD, Appelbe A, Cukier K, Kotowicz M, McGee SL. 2017. Obesity and type 2 diabetes have additive effects on left ventricular remodelling in normotensive patients-a cross sectional study. Cardiovasc Diabetol. 16(1):21.
   PubMed Web of Science ®Google Scholar
• Dennis EA, Norris PC. 2015. Eicosanoid storm in infection and inflammation. Nat Rev Immunol. 15(8):511–523.
   PubMed Web of Science ®Google Scholar
• Deschamps JD, Gautschi JT, Whitman S, Johnson TA, Gassner NC, Crews P, Holman TR. 2007. Discovery of platelet-type 12-human lipoxygenase selective inhibitors by high-throughput screening of structurally diverse libraries. Bioorg Med Chem. 15(22):6900–6908.
   PubMed Web of Science ®Google Scholar
• Diabetes.ca. 2017. Diabetes Canada 2018 pre-budget submission: 90-90-90 - measurable change and improved productivity by 2021.
   Google Scholar
• Ding XZ, Iversen P, Cluck MW, Knezetic JA, Adrian TE. 1999. Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells. Biochem Biophys Res Commun. 261(1):218–223.
   PubMed Web of Science ®Google Scholar
• Dobaczewski M, Chen W, Frangogiannis NG. 2011. Transforming growth factor (tgf)-β signaling in cardiac remodeling. J Mol Cell Cardiol. 51(4):600–606.
   PubMed Web of Science ®Google Scholar
• Dobrian AD, Huyck RW, Glenn L, Gottipati V, Haynes BA, Hansson GI, Marley A, McPheat WL, Nadler JL. 2018. Activation of the 12/15 lipoxygenase pathway accompanies metabolic decline in db/db pre-diabetic mice. Prostaglandins Other Lipid Mediat. 136:23–32.
   PubMed Web of Science ®Google Scholar
• Dobrian AD, Morris MA, Taylor-Fishwick DA, Holman TR, Imai Y, Mirmira RG, Nadler JL. 2019. Role of the 12-lipoxygenase pathway in diabetes pathogenesis and complications. Pharmacol Ther. 195:100–110.
   PubMed Web of Science ®Google Scholar
• Doroshow JH, Locker GY, Myers CE. 1980. Enzymatic defenses of the mouse heart against reactive oxygen metabolites: Alterations produced by doxorubicin. J Clin Invest. 65(1):128–135.
   PubMed Web of Science ®Google Scholar
• Drosatos K, Schulze PC. 2013. Cardiac lipotoxicity: Molecular pathways and therapeutic implications. Curr Heart Fail Rep. 10(2):109–121.
   PubMedGoogle Scholar
• Eguchi K, Boden-Albala B, Jin Z, Rundek T, Sacco RL, Homma S, Di Tullio MR. 2008. Association between diabetes mellitus and left ventricular hypertrophy in a multiethnic population. Am J Cardiol. 101(12):1787–1791.
   PubMed Web of Science ®Google Scholar
• Ehses JA, Donath MY. 2015. Targeting 12-lipoxygenase as a novel strategy to combat the effects of inflammation on beta cells in diabetes. Diabetologia. 58(3):425–428.
   PubMed Web of Science ®Google Scholar
• Eid AA, Gorin Y, Fagg BM, Maalouf R, Barnes JL, Block K, Abboud HE. 2009. Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases. Role of Cytochrome P450 and NADPH Oxidases. 58(5):1201–1211.
   Google Scholar
• Elmarakby AA, Faulkner J, Al-Shabrawey M, Wang M-H, Maddipati KR, Imig JD. 2011. Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes. Am J Physiol Regul Integr Comp Physiol. 301(5):R1307–R1317.
   PubMed Web of Science ®Google Scholar
• Elshenawy OH, Anwar-Mohamed A, El-Kadi AO. 2013. 20-hydroxyeicosatetraenoic acid is a potential therapeutic target in cardiovascular diseases. Curr Drug Metab. 14(6):706–719.
   PubMed Web of Science ®Google Scholar
• El-Sherbeni AA, El-Kadi AOS. 2014. Alterations in cytochrome p450-derived arachidonic acid metabolism during pressure overload-induced cardiac hypertrophy. Biochem Pharmacol. 87(3):456–466.
   PubMed Web of Science ®Google Scholar
• Erion DM, Shulman GI. 2010. Diacylglycerol-mediated insulin resistance. Nat Med. 16(4):400–402.
   PubMed Web of Science ®Google Scholar
• Falck JR, Manna S, Moltz J, Chacos N, Capdevila J. 1983. Epoxyeicosatrienoic acids stimulate glucagon and insulin release from isolated rat pancreatic islets. Biochem Biophys Res Commun. 114(2):743–749.
   PubMed Web of Science ®Google Scholar
• Felber JP, Golay A. 2002. Pathways from obesity to diabetes. Int J Obes Relat Metab Disord. 26(Suppl 2):S39–S45.
   PubMed Web of Science ®Google Scholar
• Fiordaliso F, Li B, Latini R, Sonnenblick EH, Anversa P, Leri A, Kajstura J. 2000. Myocyte death in streptozotocin-induced diabetes in rats in angiotensin ii- dependent. Lab Invest. 80(4):513–527.
   PubMed Web of Science ®Google Scholar
• Fleming I. 2007. Discreet regulators of homeostasis: Epoxyeicosatrienoic acids, cytochrome p450 epoxygenases and vascular inflammation. Trends Pharmacol Sci. 28(9):448–452.
   PubMed Web of Science ®Google Scholar
• Frustaci A, Kajstura J, Chimenti C, Jakoniuk I, Leri A, Maseri A, Nadal-Ginard B, Anversa P. 2000. Myocardial cell death in human diabetes. Circ Res. 87(12):1123–1132.
   PubMed Web of Science ®Google Scholar
• Funk CD. 2001. Prostaglandins and leukotrienes: Advances in eicosanoid biology. Science. 294(5548):1871–1875.
   PubMed Web of Science ®Google Scholar
• Gauthier KM, Deeter C, Krishna UM, Reddy YK, Bondlela M, Falck JR, Campbell WB. 2002. 14,15-epoxyeicosa-5(z)-enoic acid: a selective epoxyeicosatrienoic acid antagonist that inhibits endothelium-dependent hyperpolarization and relaxation in coronary arteries. Circ Res. 90(9):1028–1036.
   PubMed Web of Science ®Google Scholar
• Gebremedhin D, Harder DR, Pratt PF, Campbell WB. 1998. Bioassay of an endothelium-derived hyperpolarizing factor from bovine coronary arteries: Role of a cytochrome p450 metabolite. J Vasc Res. 35(4):274–284.
   PubMed Web of Science ®Google Scholar
• Gilani A, Agostinucci K, Hossain S, Pascale JV, Garcia V, Adebesin AM, Falck JR, Schwartzman ML. 2021. 20-hete interferes with insulin signaling and contributes to obesity-driven insulin resistance. Prostaglandins Other Lipid Mediat. 152:106485.
   PubMed Web of Science ®Google Scholar
• Gilani A, Pandey V, Garcia V, Agostinucci K, Singh SP, Schragenheim J, Bellner L, Falck JR, Paudyal MP, Capdevila JH, et al. 2018. High-fat diet-induced obesity and insulin resistance in cyp4a14(-/-) mice is mediated by 20-hete. Am J Physiol Regul Integr Comp Physiol. 315(5):R934–R944.
   PubMed Web of Science ®Google Scholar
• Giuliani C, Bucci I, Napolitano G. 2018. The role of the transcription factor nuclear factor-kappa b in thyroid autoimmunity and cancer. Front Endocrinol (Lausanne). 9(:471.
   PubMed Web of Science ®Google Scholar
• Goldin A, Beckman JA, Schmidt AM, Creager MA. 2006. Advanced glycation end products: Sparking the development of diabetic vascular injury. Circulation. 114(6):597–605.
   PubMed Web of Science ®Google Scholar
• Goodpaster BH, Kelley DE. 2002. Skeletal muscle triglyceride: Marker or mediator of obesity-induced insulin resistance in type 2 diabetes mellitus? Curr Diab Rep. 2(3):216–222.
   PubMedGoogle Scholar
• Gross GJ, Gauthier KM, Moore J, Falck JR, Hammock BD, Campbell WB, Nithipatikom K. 2008. Effects of the selective eet antagonist, 14, 15-eeze, on cardioprotection produced by exogenous or endogenous eets in the canine heart. Am J Physiol - Heart Circ Physiol. 294(6):H2838–H2844.
   PubMed Web of Science ®Google Scholar
• Hanif A, Aung M, Prunty M, Park H, Iuvone PM, Pardue MT. 2016. Regulating arachidonic acid metabolites ameliorates neurovascular defects and subsequent visual deficits in stz rats. Invest Ophthalmol Vis Sci. 57(12):e0162147.
   Web of Science ®Google Scholar
• Hanna VS, Hafez EAA. 2018. Synopsis of arachidonic acid metabolism: A review. J Adv Res. 11:23–32.
   PubMed Web of Science ®Google Scholar
• Hao P, Yang J, Liu Y, Zhang M, Zhang K, Gao F, Chen Y, Zhang C, Zhang Y. 2015. Combination of angiotensin-(1-7) with perindopril is better than single therapy in ameliorating diabetic cardiomyopathy. Sci Rep. 5:8794–8794.
   PubMed Web of Science ®Google Scholar
• Hardwick JP. 2008. Cytochrome p450 omega hydroxylase (cyp4) function in fatty acid metabolism and metabolic diseases. Biochem Pharmacol. 75(12):2263–2275.
   PubMed Web of Science ®Google Scholar
• Hastings N, Agaba M, Tocher DR, Leaver MJ, Dick JR, Sargent JR, Teale AJ. 2001. A vertebrate fatty acid desaturase with Delta 5 and Delta 6 activities. Proc Natl Acad Sci USA. 98(25):14304–14309.
   PubMed Web of Science ®Google Scholar
• Hayabuchi Y, Nakaya Y, Matsuoka S, Kuroda Y. 1998. Endothelium-derived hyperpolarizing factor activates ca2+-activated k + channels in porcine coronary artery smooth muscle cells. J Cardiovasc Pharmacol. 32(4):642–649.
   PubMed Web of Science ®Google Scholar
• He Z, Zhang X, Chen C, Wen Z, Hoopes SL, Zeldin DC, Wang DW. 2015. Cardiomyocyte-specific expression of cyp2j2 prevents development of cardiac remodelling induced by angiotensin ii. Cardiovasc Res. 105(3):304–317.
   PubMed Web of Science ®Google Scholar
• Hecker M, Bara AT, Bauersachs J, Busse R. 1994. Characterization of endothelium-derived hyperpolarizing factor as a cytochrome p450-derived arachidonic acid metabolite in mammals. J Physiol. 481(2):407–414.
   PubMed Web of Science ®Google Scholar
• Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RA, Warnholtz A, et al. 2001. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res. 88(2):E14–22.
   PubMed Web of Science ®Google Scholar
• Hoehn KL, Salmon AB, Hohnen-Behrens C, Turner N, Hoy AJ, Maghzal GJ, Stocker R, Van Remmen H, Kraegen EW, Cooney GJ, et al. 2009. Insulin resistance is a cellular antioxidant defense mechanism. Proc Natl Acad Sci USA. 106(42):17787–17792.
   PubMed Web of Science ®Google Scholar
• Holinstat M, Boutaud O, Apopa PL, Vesci J, Bala M, Oates JA, Hamm HE. 2011. Protease-activated receptor signaling in platelets activates cytosolic phospholipase a2α differently for cyclooxygenase-1 and 12-lipoxygenase catalysis. Arterioscler Thromb Vasc Biol. 31(2):435–442.
   PubMed Web of Science ®Google Scholar
• Holland WL, Summers SA. 2008. Sphingolipids, insulin resistance, and metabolic disease: New insights from in vivo manipulation of sphingolipid metabolism. Endocr Rev. 29(4):381–402.
   PubMed Web of Science ®Google Scholar
• Hu S, Kim HS. 1993. Activation of k + channel in vascular smooth muscles by cytochrome p450 metabolites of arachidonic acid. Eur J Pharmacol. 230(2):215–221.
   PubMed Web of Science ®Google Scholar
• Hulver MW, Berggren JR, Cortright RN, Dudek RW, Thompson RP, Pories WJ, MacDonald KG, Cline GW, Shulman GI, Dohm GL, et al. 2003. Skeletal muscle lipid metabolism with obesity. Am J Physiol Endocrinol Metab. 284(4):E741–E747.
   PubMed Web of Science ®Google Scholar
• Hussain H, Shornick LP, Shannon VR, Wilson JD, Funk CD, Pentland AP, Holtzman MJ. 1994. Epidermis contains platelet-type 12-lipoxygenase that is overexpressed in germinal layer keratinocytes in psoriasis. Am J Physiol. 266(1 Pt 1):C243–253.
   PubMed Web of Science ®Google Scholar
• Huynh K, Kiriazis H, Du XJ, Love JE, Gray SP, Jandeleit-Dahm KA, McMullen JR, Ritchie RH. 2013. Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in mice. Free Radic Biol Med. 60:307–317.
   PubMed Web of Science ®Google Scholar
• Iltis I, Kober F, Dalmasso C, Cozzone PJ, Bernard M. 2005. Noninvasive characterization of myocardial blood flow in diabetic, hypertensive, and diabetic-hypertensive rats using spin-labeling mri. Microcirculation. 12(8):607–614.
   PubMed Web of Science ®Google Scholar
• Imai Y, Dobrian AD, Morris MA, Taylor-Fishwick DA, Nadler JL. 2016. Lipids and immunoinflammatory pathways of beta cell destruction. Diabetologia. 59(4):673–678.
   PubMed Web of Science ®Google Scholar
• Imig JD. 2005. Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases. Am J Physiol Renal Physiol. 289(3):F496–F503.
   PubMed Web of Science ®Google Scholar
• Imig JD. 2012. Epoxides and soluble epoxide hydrolase in cardiovascular physiology. Physiol Rev. 92(1):101–130.
   PubMed Web of Science ®Google Scholar
• Imig JD. 2015. Epoxyeicosatrienoic acids, hypertension, and kidney injury. Hypertension. 65(3):476–482.
   PubMed Web of Science ®Google Scholar
• Imig JD. 2016. Epoxyeicosatrienoic acids and 20-hydroxyeicosatetraenoic acid on endothelial and vascular function. Adv Pharmacol. 77:105–141.
   PubMedGoogle Scholar
• Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M, et al. 2000. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes. 49(11):1939–1945.
   PubMed Web of Science ®Google Scholar
• Issan Y, Hochhauser E, Guo A, Gotlinger KH, Kornowski R, Leshem-Lev D, Lev E, Porat E, Snir E, Thompson CI, et al. 2013. Elevated level of pro-inflammatory eicosanoids and epc dysfunction in diabetic patients with cardiac ischemia. Prostaglandins Other Lipid Mediat. 100-101:15–21.
   PubMed Web of Science ®Google Scholar
• Jansen M, Ten Klooster JP, Offerhaus GJ, Clevers H. 2009. Lkb1 and ampk family signaling: The intimate link between cell polarity and energy metabolism. Physiol Rev. 89(3):777–798.
   PubMed Web of Science ®Google Scholar
• Jia G, Habibi J, DeMarco VG, Martinez-Lemus LA, Ma L, Whaley-Connell AT, Aroor AR, Domeier TL, Zhu Y, Meininger GA, et al. 2015. Endothelial mineralocorticoid receptor deletion prevents diet-induced cardiac diastolic dysfunction in females. Hypertension. 66(6):1159–1167.
   PubMed Web of Science ®Google Scholar
• Jia G, Whaley-Connell A, Sowers JR. 2018. Diabetic cardiomyopathy: A hyperglycaemia- and insulin-resistance-induced heart disease. Diabetologia. 61(1):21–28.
   PubMed Web of Science ®Google Scholar
• Joseph G, Soler A, Hutcheson R, Hunter I, Bradford C, Hutcheson B, Gotlinger KH, Jiang H, Falck JR, Proctor S, et al. 2017. Elevated 20-hete impairs coronary collateral growth in metabolic syndrome via endothelial dysfunction. Am J Physiol Heart Circ Physiol. 312(3):H528–H540.
   PubMed Web of Science ®Google Scholar
• Joseph G, Soler A, Hutcheson R, Hunter I, Bradford C, Hutcheson B, Gotlinger KH, Jiang H, Falck JR, Proctor S, et al. 2017. Elevated 20-hete impairs coronary collateral growth in metabolic syndrome via endothelial dysfunction. Am J Physiol Heart Circ Physiol. 312(3):H528–h540.
   PubMed Web of Science ®Google Scholar
• Kajstura J, Fiordaliso F, Andreoli AM, Li B, Chimenti S, Medow MS, Limana F, Nadal-Ginard B, Leri A, Anversa P. 2001. Igf-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin ii-mediated oxidative stress. Diabetes. 50(6):1414–1424.
   PubMed Web of Science ®Google Scholar
• Kaneto H, Nakatani Y, Kawamori D, Miyatsuka T, Matsuoka T-a. 2004. Involvement of oxidative stress and the jnk pathway in glucose toxicity. Rev Diabet Stud. 1(4):165–174.
   PubMedGoogle Scholar
• Kannel WB, Hjortland M, Castelli WP. 1974. Role of diabetes in congestive heart failure: The framingham study. Am J Cardiol. 34(1):29–34.
   PubMed Web of Science ®Google Scholar
• Karbasforooshan H, Karimi G. 2017. The role of sirt1 in diabetic cardiomyopathy. Biomed Pharmacother. 90:386–392.
   PubMed Web of Science ®Google Scholar
• Katakam PVG, Hoenig M, Ujhelyi MR, Miller AW. 2000. Cytochrome p450 activity and endothelial dysfunction in insulin resistance. J Vasc Res. 37(5):426–434.
   PubMed Web of Science ®Google Scholar
• Katakami N. 2017. Mechanism of development of atherosclerosis and cardiovascular disease in diabetes mellitus. J Atheroscler Thromb. 25(1):27–39.
   PubMed Web of Science ®Google Scholar
• Kehl F, Cambj-Sapunar L, Maier KG, Miyata N, Kametani S, Okamoto H, Hudetz AG, Schulte ML, Zagorac D, Harder DR, et al. 2002. 20-hete contributes to the acute fall in cerebral blood flow after subarachnoid hemorrhage in the rat. Am J Physiol Heart Circ Physiol. 282(4):H1556–H1565.
   PubMed Web of Science ®Google Scholar
• Kenyon V, Rai G, Jadhav A, Schultz L, Armstrong M, Jameson JB, 2nd, Perry S, Joshi N, Bougie JM, Leister W, et al. 2011. Discovery of potent and selective inhibitors of human platelet-type 12- lipoxygenase. J Med Chem. 54(15):5485–5497.
   PubMed Web of Science ®Google Scholar
• Khavandi K, Khavandi A, Asghar O, Greenstein A, Withers S, Heagerty AM, Malik RA. 2009. Diabetic cardiomyopathy-a distinct disease? Best Pract Res Clin Endocrinol Metab. 23(3):347–360.
   PubMed Web of Science ®Google Scholar
• Khoder-Agha F, Kietzmann T. 2021. The glyco-redox interplay: Principles and consequences on the role of reactive oxygen species during protein glycosylation. Redox Biol. 42:101888.
   PubMed Web of Science ®Google Scholar
• Kim DH, Vanella L, Inoue K, Burgess A, Gotlinger K, Manthati VL, Koduru SR, Zeldin DC, Falck JR, Schwartzman ML, et al. 2010. Epoxyeicosatrienoic acid agonist regulates human mesenchymal stem cell-derived adipocytes through activation of ho-1-pakt signaling and a decrease in pparγ. Stem Cells Dev. 19(12):1863–1873.
   PubMed Web of Science ®Google Scholar
• Klett EL, Chen S, Edin ML, Li LO, Ilkayeva O, Zeldin DC, Newgard CB, Coleman RA. 2013. Diminished acyl-coa synthetase isoform 4 activity in ins 832/13 cells reduces cellular epoxyeicosatrienoic acid levels and results in impaired glucose-stimulated insulin secretion*. J Biol Chem. 288(30):21618–21629.
   PubMed Web of Science ®Google Scholar
• Kranstuber AL, Del Rio C, Biesiadecki BJ, Hamlin RL, Ottobre J, Gyorke S, Lacombe VA. 2012. Advanced glycation end product cross-link breaker attenuates diabetes-induced cardiac dysfunction by improving sarcoplasmic reticulum calcium handling. Front Physiol. 3:292.
   PubMed Web of Science ®Google Scholar
• Kroetz DL, Xu F. 2005. Regulation and inhibition of arachidonic acid omega-hydroxylases and 20-HETE formation . Annu Rev Pharmacol Toxicol. 45:413–438.
   PubMed Web of Science ®Google Scholar
• Krötz F, Riexinger T, Buerkle MA, Nithipatikom K, Gloe T, Sohn HY, Campbell WB, Pohl U. 2004. Membrane-potential-dependent inhibition of platelet adhesion to endothelial cells by epoxyeicosatrienoic acids. Arterioscler Thromb Vasc Biol. 24(3):595–600.
   PubMed Web of Science ®Google Scholar
• Kühn H, O'Donnell VB. 2006. Inflammation and immune regulation by 12/15-lipoxygenases. Prog Lipid Res. 45(4):334–356.
   PubMed Web of Science ®Google Scholar
• Kuzan A. 2021. Toxicity of advanced glycation end products (review). Biomed Rep. 14(5):46.
   PubMed Web of Science ®Google Scholar
• Laffer CL, Laniado-Schwartzman M, Nasjletti A, Elijovich F. 2004. 20-hete and circulating insulin in essential hypertension with obesity. Hypertension. 43(2):388–392.
   PubMed Web of Science ®Google Scholar
• Lai G, Wu J, Liu X, Zhao Y. 2012. 20-hete induces hyperglycemia through the camp/pka-phk-gp pathway. Mol Endocrinol. 26(11):1907–1916.
   PubMedGoogle Scholar
• Lazaar AL, Yang L, Boardley RL, Goyal NS, Robertson J, Baldwin SJ, Newby DE, Wilkinson IB, Tal-Singer R, Mayer RJ, et al. 2016. Pharmacokinetics, pharmacodynamics and adverse event profile of gsk2256294, a novel soluble epoxide hydrolase inhibitor. Br J Clin Pharmacol. 81(5):971–979.
   PubMed Web of Science ®Google Scholar
• LeBlanc AG, Jun Gao Y, McRae L, Pelletier C. 2019. At-a-glance - twenty years of diabetes surveillance using the canadian chronic disease surveillance system. Health Promot Chronic Dis Prev Can. 39(11):306–309.
   PubMed Web of Science ®Google Scholar
• Leon BM, Maddox TM. 2015. Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes. 6(13):1246–1258.
   PubMed Web of Science ®Google Scholar
• Li G, Barrett EJ, Barrett MO, Cao W, Liu Z. 2007. Tumor necrosis factor-alpha induces insulin resistance in endothelial cells via a p38 mitogen-activated protein kinase-dependent pathway. Endocrinology. 148(7):3356–3363.
   PubMed Web of Science ®Google Scholar
• Li N, Liu J-Y, Timofeyev V, Qiu H, Hwang SH, Tuteja D, Lu L, Yang J, Mochida H, Low R, et al. 2009. Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: Insight gained using metabolomic approaches. J Mol Cell Cardiol. 47(6):835–845.
   PubMed Web of Science ®Google Scholar
• Li PL, Campbell WB. 1997. Epoxyeicosatrienoic acids activate k + channels in coronary smooth muscle through a guanine nucleotide binding protein. Circ Res. 80(6):877–884.
   PubMed Web of Science ®Google Scholar
• Li X, Chu G, Zhu F, Zheng Z, Wang X, Zhang G, Wang F. 2020. Epoxyeicosatrienoic acid prevents maladaptive remodeling in pressure overload by targeting calcineurin/nfat and smad-7. Exp Cell Res. 386(1):111716.
   PubMed Web of Science ®Google Scholar
• Li X, Zhao G, Ma B, Li R, Hong J, Liu S, Wang DW. 2014. 20-hydroxyeicosatetraenoic acid impairs endothelial insulin signaling by inducing phosphorylation of the insulin receptor substrate-1 at ser616. PLoS One. 9(4):e95841.
   PubMed Web of Science ®Google Scholar
• Lin X, Xu Y, Pan X, Xu J, Ding Y, Sun X, Song X, Ren Y, Shan P-F. 2020. Global, regional, and national burden and trend of diabetes in 195 countries and territories: An analysis from 1990 to 2025. Sci Rep. 10(1):14790.
   PubMed Web of Science ®Google Scholar
• Lorenzo O, Picatoste B, Ares-Carrasco S, Ramírez E, Egido J, Tuñón J. 2011. Potential role of nuclear factor κb in diabetic cardiomyopathy. Mediators Inflamm. 2011:652097.
   PubMed Web of Science ®Google Scholar
• Lu T, Ye D, Wang X, Seubert JM, Graves JP, Bradbury JA, Zeldin DC, Lee H-C. 2006. Cardiac and vascular katp channels in rats are activated by endogenous epoxyeicosatrienoic acids through different mechanisms. J Physiol. 575(Pt 2):627–644.
   PubMed Web of Science ®Google Scholar
• Luo P, Chang H-H, Zhou Y, Zhang S, Hwang SH, Morisseau C, Wang C-Y, Inscho EW, Hammock BD, Wang M-H. 2010. Inhibition or deletion of soluble epoxide hydrolase prevents hyperglycemia, promotes insulin secretion, and reduces islet apoptosis. J Pharmacol Exp Ther. 334(2):430–438.
   PubMed Web of Science ®Google Scholar
• Luo P, Zhou Y, Chang H-H, Zhang J, Seki T, Wang C-Y, Inscho EW, Wang M-H. 2009. Glomerular 20-hete, eets, and tgf-β1 in diabetic nephropathy. Am J Physiol Renal Physiol. 296(3):F556–F563.
   PubMed Web of Science ®Google Scholar
• Luria A, Bettaieb A, Xi Y, Shieh GJ, Liu HC, Inoue H, Tsai HJ, Imig JD, Haj FG, Hammock BD. 2011. Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance. Proc Natl Acad Sci USA. 108(22):9038–9043.
   PubMed Web of Science ®Google Scholar
• Ma B, Xiong X, Chen C, Li H, Xu X, Li X, Li R, Chen G, Dackor RT, Zeldin DC, et al. 2013. Cardiac-specific overexpression of cyp2j2 attenuates diabetic cardiomyopathy in male streptozotocin-induced diabetic mice. Endocrinology. 154(8):2843–2856.
   PubMed Web of Science ®Google Scholar
• Ma K, Nunemaker CS, Wu R, Chakrabarti SK, Taylor-Fishwick DA, Nadler JL. 2010. 12-lipoxygenase products reduce insulin secretion and {beta}-cell viability in human islets. J Clin Endocrinol Metab. 95(2):887–893.
   PubMed Web of Science ®Google Scholar
• Maayah ZH, El-Kadi AOS. 2016. The role of mid-chain hydroxyeicosatetraenoic acids in the pathogenesis of hypertension and cardiac hypertrophy. Arch Toxicol. 90(1):119–136.
   PubMed Web of Science ®Google Scholar
• Maayah ZH, McGinn E, Al Batran R, Gopal K, Ussher JR, El-Kadi AOS. 2019. Role of cytochrome p450 and soluble epoxide hydrolase enzymes and their associated metabolites in the pathogenesis of diabetic cardiomyopathy. J Cardiovasc Pharmacol. 74(3):235–245.
   PubMed Web of Science ®Google Scholar
• Maisch B, Alter P, Pankuweit S. 2011. Diabetic cardiomyopathy-fact or fiction? Herz. 36(2):102–115.
   PubMed Web of Science ®Google Scholar
• Mangali S, Bhat A, Jadhav K, Kalra J, Sriram D, Vamsi Krishna Venuganti V, Dhar A. 2020. Upregulation of pkr pathway mediates glucolipotoxicity induced diabetic cardiomyopathy in vivo in wistar rats and in vitro in cultured cardiomyocytes. Biochem Pharmacol. 177:113948.
   PubMed Web of Science ®Google Scholar
• Mangali S, Bhat A, Udumula MP, Dhar I, Sriram D, Dhar A. 2019. Inhibition of protein kinase r protects against palmitic acid-induced inflammation, oxidative stress, and apoptosis through the JNK/NF-kB/NLRP3 pathway in cultured H9C2 cardiomyocytes. J Cell Biochem. 120(3):3651–3663.
   PubMed Web of Science ®Google Scholar
• Mazière C, Mazière JC. 2009. Activation of transcription factors and gene expression by oxidized low-density lipoprotein. Free Radic Biol Med. 46(2):127–137.
   PubMed Web of Science ®Google Scholar
• McDuffie M, Maybee NA, Keller SR, Stevens BK, Garmey JC, Morris MA, Kropf E, Rival C, Ma K, Carter JD, et al. 2008. Nonobese diabetic (nod) mice congenic for a targeted deletion of 12/15-lipoxygenase are protected from autoimmune diabetes. Diabetes. 57(1):199–208.
   PubMed Web of Science ®Google Scholar
• Medhora M, Daniels J, Mundey K, Fisslthaler B, Busse R, Jacobs ER, Harder DR. 2003. Epoxygenase-driven angiogenesis in human lung microvascular endothelial cells. Am J Physiol Heart Circ Physiol. 284(1):H215–H224.
   PubMed Web of Science ®Google Scholar
• Michaelis UR, Fisslthaler B, Barbosa-Sicard E, Falck JR, Fleming I, Busse R. 2005. Cytochrome p450 epoxygenases 2c8 and 2c9 are implicated in hypoxia-induced endothelial cell migration and angiogenesis. J Cell Sci. 118(Pt 23):5489–5498.
   PubMed Web of Science ®Google Scholar
• Miller AW, Hoenig ME, Ujhelyi MR. 1998. Mechanisms of impaired endothelial function associated with insulin resistance. J Cardiovasc Pharmacol Ther. 3(2):125–134.
   PubMedGoogle Scholar
• Miller AW, Katakam PV, Ujhelyi MR. 1999. Impaired endothelium-mediated relaxation in coronary arteries from insulin-resistant rats. J Vasc Res. 36(5):385–392.
   PubMed Web of Science ®Google Scholar
• Miyamoto S, Murphy AN, Brown JH. 2009. Akt mediated mitochondrial protection in the heart: Metabolic and survival pathways to the rescue. J Bioenerg Biomembr. 41(2):169–180.
   PubMed Web of Science ®Google Scholar
• Miyata N, Roman RJ. 2005. Role of 20-hydroxyeicosatetraenoic acid (20-hete) in vascular system. J Smooth Muscle Res. 41(4):175–193.
   PubMedGoogle Scholar
• Miyata N, Taniguchi K, Seki T, Ishimoto T, Sato-Watanabe M, Yasuda Y, Doi M, Kametani S, Tomishima Y, Ueki T, et al. 2001. Het0016, a potent and selective inhibitor of 20-hete synthesizing enzyme. Br J Pharmacol. 133(3):325–329.
   PubMed Web of Science ®Google Scholar
• Morisseau C, Hammock BD. 2013. Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health. Annu Rev Pharmacol Toxicol. 53(1):37–58.
   PubMed Web of Science ®Google Scholar
• Mustafa S, Sharma V, McNeill JH. 2009. Insulin resistance and endothelial dysfunction: Are epoxyeicosatrienoic acids the link? Exp Clin Cardiol. 14(2):e41–e50.
   PubMedGoogle Scholar
• Nagle CA, Klett EL, Coleman RA. 2009. Hepatic triacylglycerol accumulation and insulin resistance. J Lipid Res. 50:S74–S79.
   PubMed Web of Science ®Google Scholar
• Najemnikova E, Rodgers CD, Locke M. 2007. Altered heat stress response following streptozotocin-induced diabetes. Cell Stress Chaper. 12(4):342–352.
   PubMed Web of Science ®Google Scholar
• Nakamura T, Sato M, Kakinuma H, Miyata N, Taniguchi K, Bando K, Koda A, Kameo K. 2003. Pyrazole and isoxazole derivatives as new, potent, and selective 20-hydroxy-5,8,11,14-eicosatetraenoic acid synthase inhibitors. J Med Chem. 46(25):5416–5427.
   PubMed Web of Science ®Google Scholar
• Nakano M, Kelly EJ, Rettie AE. 2009. Expression and characterization of cyp4v2 as a fatty acid omega-hydroxylase. Drug Metab Dispos. 37(11):2119–2122.
   PubMed Web of Science ®Google Scholar
• Nazarewicz RR, Zenebe WJ, Parihar A, Parihar MS, Vaccaro M, Rink C, Sen CK, Ghafourifar P. 2007. 12(s)-hydroperoxyeicosatetraenoic acid (12-hete) increases mitochondrial nitric oxide by increasing intramitochondrial calcium. Arch Biochem Biophys. 468(1):114–120.
   PubMed Web of Science ®Google Scholar
• Ng CY, Kannan S, Chen YJ, Tan FCK, Ong WY, Go ML, Verma CS, Low C-M, Lam Y. 2017. A new generation of arachidonic acid analogues as potential neurological agent targeting cytosolic phospholipase a2. Sci Rep. 7(1):13683.
   PubMed Web of Science ®Google Scholar
• Nishikawa Y, Stepp DW, Chilian WM. 1999. In vivo location and mechanism of edhf-mediated vasodilation in canine coronary microcirculation. Am J Physiol. 277(3):H1252–1259.
   PubMedGoogle Scholar
• Node K, Huo Y, Ruan X, Yang B, Spiecker M, Ley K, Zeldin DC, Liao JK. 1999. Anti-inflammatory properties of cytochrome p450 epoxygenase-derived eicosanoids. Science (New York, NY). 285(5431):1276–1279.
   Google Scholar
• Node K, Ruan XL, Dai J, Yang SX, Graham L, Zeldin DC, Liao JK. 2001. Activation of galpha s mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids. J Biol Chem. 276(19):15983–15989.
   PubMed Web of Science ®Google Scholar
• Norton GR, Candy G, Woodiwiss AJ. 1996. Aminoguanidine prevents the decreased myocardial compliance produced by streptozotocin-induced diabetes mellitus in rats. Circulation. 93(10):1905–1912.
   PubMed Web of Science ®Google Scholar
• Nowotny K, Jung T, Höhn A, Weber D, Grune T. 2015. Advanced glycation end products and oxidative stress in type 2 diabetes mellitus. Biomolecules. 5(1):194–222.
   PubMed Web of Science ®Google Scholar
• Oh YS, BAe GD, BAeK DJ, PARK E-Y, JUN H-S. 2018. Fatty acid-induced lipotoxicity in pancreatic beta-cells during development of type 2 diabetes. Front Endocrinol. 9(384):384.
   PubMed Web of Science ®Google Scholar
• Ohkuwa T, Sato Y, Naoi M. 1995. Hydroxyl radical formation in diabetic rats induced by streptozotocin. Life Sci. 56(21):1789–1798.
   PubMed Web of Science ®Google Scholar
• Ozturk N, Uslu S, Ozdemir S. 2021. Diabetes-induced changes in cardiac voltage-gated ion channels. World J Diabetes. 12(1):1–18.
   PubMed Web of Science ®Google Scholar
• Parhofer KG. 2015. Interaction between glucose and lipid metabolism: More than diabetic dyslipidemia. Diabetes Metab J. 39(5):353–362.
   PubMed Web of Science ®Google Scholar
• Park EC, Kim SI, Hong Y, Hwang JW, Cho G-S, Cha H-N, Han J-K, Yun C-H, Park S-Y, Jang I-S, et al. 2014. Inhibition of cyp4a reduces hepatic endoplasmic reticulum stress and features of diabetes in mice. Gastroenterology. 147(4):860–869.
   PubMed Web of Science ®Google Scholar
• Park F, Sweeney WE, Jia G, Roman RJ, Avner ED. 2008. 20-hete mediates proliferation of renal epithelial cells in polycystic kidney disease. J Am Soc Nephrol. 19(10):1929–1939.
   PubMed Web of Science ®Google Scholar
• Parkinson OT, Kelly EJ, Bezabih E, Whittington D, Rettie AE. 2012. Bioactivation of 4-ipomeanol by a cyp4b enzyme in bovine lung and inhibition by het0016. J Vet Pharmacol Ther. 35(4):402–405.
   PubMed Web of Science ®Google Scholar
• Pennathur S, Wagner JD, Leeuwenburgh C, Litwak KN, Heinecke JW. 2001. A hydroxyl radical-like species oxidizes cynomolgus monkey artery wall proteins in early diabetic vascular disease. J Clin Invest. 107(7):853–860.
   PubMed Web of Science ®Google Scholar
• Popp R, Bauersachs J, Hecker M, Fleming I, Busse R. 1996. A transferable, beta-naphthoflavone-inducible, hyperpolarizing factor is synthesized by native and cultured porcine coronary endothelial cells. J Physiol. 497(3):699–709.
   PubMed Web of Science ®Google Scholar
• Puthanveetil P, Zhang D, Wang Y, Wang F, Wan A, Abrahani A, Rodrigues B. 2012. Diabetes triggers a parp1 mediated death pathway in the heart through participation of foxo1. J Mol Cell Cardiol. 53(5):677–686.
   PubMed Web of Science ®Google Scholar
• Quilley J, McGiff JC. 2000. Is edhf an epoxyeicosatrienoic acid? Trends Pharmacol Sci. 21(4):121–124.
   PubMed Web of Science ®Google Scholar
• Rachek LI. 2014. Free fatty acids and skeletal muscle insulin resistance. Prog Mol Biol Transl Sci. 121:267–292.
   PubMed Web of Science ®Google Scholar
• Ramirez CE, Shuey MM, Milne GL, Gilbert K, Hui N, Yu C, Luther JM, Brown NJ. 2014. Arg287gln variant of ephx2 and epoxyeicosatrienoic acids are associated with insulin sensitivity in humans. Prostaglandins Other Lipid Mediat. 113-115:38–44.
   PubMed Web of Science ®Google Scholar
• Riehle C, Abel ED. 2016. Insulin signaling and heart failure. Circ Res. 118(7):1151–1169.
   PubMed Web of Science ®Google Scholar
• Roche C, Besnier M, Cassel R, Harouki N, Coquerel D, Guerrot D, Nicol L, Loizon E, Remy-Jouet I, Morisseau C, et al. 2015. Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice. Am J Physiol Heart Circ Physiol. 308(9):H1020–1029.
   PubMed Web of Science ®Google Scholar
• Roman RJ. 2002. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev. 82(1):131–185.
   PubMed Web of Science ®Google Scholar
• Romashko M, Schragenheim J, Abraham NG, McClung JA. 2016. Epoxyeicosatrienoic acid as therapy for diabetic and ischemic cardiomyopathy. Trends Pharmacol Sci. 37(11):945–962.
   PubMed Web of Science ®Google Scholar
• Rösen R, Rump AFE, Rösen P. 1995. The ace-inhibitor captopril improves myocardial perfusion in spontaneously diabetic (bb) rats. Diabetologia. 38(5):509–517.
   PubMed Web of Science ®Google Scholar
• Rosolowsky M, Campbell WB. 1993. Role of pgi2 and epoxyeicosatrienoic acids in relaxation of bovine coronary arteries to arachidonic acid. Am J Physiol. 264(2 Pt 2):H327–335.
   PubMed Web of Science ®Google Scholar
• Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. 1972. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol. 30(6):595–602.
   PubMed Web of Science ®Google Scholar
• Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, IDF Diabetes Atlas Committee, et al. 2019. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the international diabetes federation diabetes atlas, 9th edition. Diabetes Res Clin Pract. 157:107843.
   PubMed Web of Science ®Google Scholar
• Samokhvalov V, Vriend J, Jamieson K, Akhnokh M, Manne R, Falck J, Seubert J. 2014. Pparγ signaling is required for mediating eets protective effects in neonatal cardiomyocytes exposed to lps. Front Pharmacol. 5(242):242.
   PubMed Web of Science ®Google Scholar
• Seubert J, Yang B, Bradbury JA, Graves J, Degraff LM, Gabel S, Gooch R, Foley J, Newman J, Mao L, et al. 2004. Enhanced postischemic functional recovery in cyp2j2 transgenic hearts involves mitochondrial atp-sensitive k + channels and p42/p44 mapk pathway. Circ Res. 95(5):506–514.
   PubMed Web of Science ®Google Scholar
• Sharma AM, Lau DC. 2013. Obesity and type 2 diabetes mellitus. Can J Diabetes. 37(2):63–64.
   PubMed Web of Science ®Google Scholar
• Shen HC, Hammock BD. 2012. Discovery of inhibitors of soluble epoxide hydrolase: A target with multiple potential therapeutic indications. J Med Chem. 55(5):1789–1808.
   PubMed Web of Science ®Google Scholar
• Sheu SS, Sharma VK, Korth M. 1987. Voltage-dependent effects of isoproterenol on cytosolic ca concentration in rat heart. Am J Physiol. 252(4 Pt 2):H697–703.
   PubMed Web of Science ®Google Scholar
• Shoieb SM, El-Sherbeni AA, El-Kadi AOS. 2019. Subterminal hydroxyeicosatetraenoic acids: Crucial lipid mediators in normal physiology and disease states. Chem Biol Interact. 299:140–150.
   PubMed Web of Science ®Google Scholar
• Singh SP, McClung JA, Bellner L, Cao J, Waldman M, Schragenheim J, Arad M, Hochhauser E, Falck JR, Weingarten JA, et al. 2018. Cyp-450 epoxygenase derived epoxyeicosatrienoic acid contribute to reversal of heart failure in obesity-induced diabetic cardiomyopathy via pgc-1 α activation. Cardiovasc Pharm Open Access. 7(1):233.
   PubMedGoogle Scholar
• Smith WL, DeWitt DL, Garavito RM. 2000. Cyclooxygenases: Structural, cellular, and molecular biology. Annu Rev Biochem. 69:145–182.
   PubMed Web of Science ®Google Scholar
• Snel M, Jonker JT, Schoones J, Lamb H, de Roos A, Pijl H, Smit JWA, Meinders AE, Jazet IM. 2012. Ectopic fat and insulin resistance: Pathophysiology and effect of diet and lifestyle interventions. Int J Endocrinol. 2012:983814–983814.
   PubMed Web of Science ®Google Scholar
• Spector AA, Fang X, Snyder GD, Weintraub NL. 2004. Epoxyeicosatrienoic acids (eets): Metabolism and biochemical function. Prog Lipid Res. 43(1):55–90.
   PubMed Web of Science ®Google Scholar
• Spector AA, Norris AW. 2007. Action of epoxyeicosatrienoic acids on cellular function. Am J Physiol Cell Physiol. 292(3):C996–C1012.
   PubMed Web of Science ®Google Scholar
• Sun J, Sui X, Bradbury JA, Zeldin DC, Conte MS, Liao JK. 2002. Inhibition of vascular smooth muscle cell migration by cytochrome p450 epoxygenase-derived eicosanoids. Circ Res. 90(9):1020–1027.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Kayama Y, Sakamoto M, Iuchi H, Shimizu I, Yoshino T, Katoh D, Nagoshi T, Tojo K, Minamino T, et al. 2015. Arachidonate 12/15-lipoxygenase-induced inflammation and oxidative stress are involved in the development of diabetic cardiomyopathy. Diabetes. 64(2):618–630.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Ueda T, Juránek I, Yamamoto S, Katoh T, Node M, Suzuki T. 2000. Hinokitiol, a selective inhibitor of the platelet-type isozyme of arachidonate 12-lipoxygenase. Biochem Biophys Res Commun. 275(3):885–889.
   PubMed Web of Science ®Google Scholar
• Tag Eldeen LA, El Sheikh M, Faisal S. 2018. The expression of cytochrome p4502j2 gene and 14, 15 epoxyeicosatrienoic acid level influence the amount of insulin secreted from human mesenchymal stem cell-derived insulin-producing cells. Bull Natl Res Cent. 42(1):12.
   Google Scholar
• Tan Y, Zhang Z, Zheng C, Wintergerst KA, Keller BB, Cai L. 2020. Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: Preclinical and clinical evidence. Nat Rev Cardiol. 17(9):585–607.
   PubMed Web of Science ®Google Scholar
• Taylor-Fishwick DA, Weaver J, Glenn L, Kuhn N, Rai G, Jadhav A, Simeonov A, Dudda A, Schmoll D, Holman TR, et al. 2015. Selective inhibition of 12-lipoxygenase protects islets and beta cells from inflammatory cytokine-mediated beta cell dysfunction. Diabetologia. 58(3):549–557.
   PubMed Web of Science ®Google Scholar
• Tesfamariam B, Brown ML, Cohen RA. 1995. 15-hydroxyeicosatetraenoic acid and diabetic endothelial dysfunction in rabbit aorta. J Cardiovasc Pharmacol. 25(5):748–755.
   PubMed Web of Science ®Google Scholar
• Theken KN, Deng Y, Schuck RN, Oni-Orisan A, Miller TM, Kannon MA, Poloyac SM, Lee CR. 2012. Enalapril reverses high-fat diet-induced alterations in cytochrome p450-mediated eicosanoid metabolism. Am J Physiol Endocrinol Metab. 302(5):E500–E509.
   PubMed Web of Science ®Google Scholar
• Thomas CP, Morgan LT, Maskrey BH, Murphy RC, Kühn H, Hazen SL, Goodall AH, Hamali HA, Collins PW, O'Donnell VB. 2010. Phospholipid-esterified eicosanoids are generated in agonist-activated human platelets and enhance tissue factor-dependent thrombin generation. J Biol Chem. 285(10):6891–6903.
   PubMed Web of Science ®Google Scholar
• Tirandi A, Carbone F, Montecucco F, Liberale L. 2022. The role of metabolic syndrome in sudden cardiac death risk: Recent evidence and future directions. Eur J Clin Invest. 52(2):e13693.
   PubMed Web of Science ®Google Scholar
• Tunaru S, Bonnavion R, Brandenburger I, Preussner J, Thomas D, Scholich K, Offermanns S. 2018. 20-hete promotes glucose-stimulated insulin secretion in an autocrine manner through ffar1. Nat Commun. 9(1):177.
   PubMed Web of Science ®Google Scholar
• Varma A, Das A, Hoke NN, Durrant DE, Salloum FN, Kukreja RC. 2012. Anti-inflammatory and cardioprotective effects of tadalafil in diabetic mice. PLoS One. 7(9):e45243-e45243.
   Web of Science ®Google Scholar
• Vasquez AM, Mouchlis VD, Dennis EA. 2018. Review of four major distinct types of human phospholipase a2. Adv Biol Regul. 67:212–218. [29248300]
   PubMedGoogle Scholar
• Wang H, Lin L, Jiang J, Wang Y, Lu ZY, Bradbury JA, Lih FB, Wang DW, Zeldin DC. 2003. Up-regulation of endothelial nitric-oxide synthase by endothelium-derived hyperpolarizing factor involves mitogen-activated protein kinase and protein kinase c signaling pathways. J Pharmacol Exp Ther. 307(2):753–764.
   PubMed Web of Science ®Google Scholar
• Wang R, Wang L, He J, Li S, Yang X, Sun P, Yuan Y, Peng J, Yan J, Du J, et al. 2019. Specific inhibition of cyp4a alleviates myocardial oxidative stress and apoptosis induced by advanced glycation end-products. Front Pharmacol. 10:876.
   PubMed Web of Science ®Google Scholar
• Ward NC, Hodgson JM, Puddey IB, Beilin LJ, Croft KD. 2006. 20-hydroxyeicosatetraenoic acid is not associated with circulating insulin in lean to overweight humans. Diab Res Clin Pract. 74(2):197–200.
   PubMed Web of Science ®Google Scholar
• Weaver JR, Holman TR, Imai Y, Jadhav A, Kenyon V, Maloney DJ, Nadler JL, Rai G, Simeonov A, DA T-F. 2012. Integration of pro-inflammatory cytokines, 12-lipoxygenase and nox-1 in pancreatic islet beta cell dysfunction. Mol Cell Endocrinol. 358(1):88–95.
   PubMed Web of Science ®Google Scholar
• Weber KT, Brilla CG. 1991. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation. 83(6):1849–1865.
   PubMed Web of Science ®Google Scholar
• Weller PF. 2016. Leukocyte lipid bodies - structure and function as "eicosasomes. Trans Am Clin Climatol Assoc. 127:328–340.
   PubMedGoogle Scholar
• Wen Y, Skidmore JC, Porter-Turner MM, Rea CA, Khokher MA, Singh BM. 2002. Relationship of glycation, antioxidant status and oxidative stress to vascular endothelial damage in diabetes. Diabetes Obes Metab. 4(5):305–308.
   PubMed Web of Science ®Google Scholar
• Wolff SP, Jiang ZY, Hunt JV. 1991. Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radic Biol Med. 10(5):339–352.
   PubMed Web of Science ®Google Scholar
• World Health Organization 2009. Global health risks: Mortality and burden of disease attributable to selected major risks. Geneva: World Health Organization.
   Google Scholar
• World Health Organization 2020. Obesity and overweight. [accessed 2021 Jan 27] https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
   Google Scholar
• Wu QD, Wang JH, Fennessy F, Redmond HP, Bouchier-Hayes D. 1999. Taurine prevents high-glucose-induced human vascular endothelial cell apoptosis. Am J Physiol. 277(6):C1229–1238.
   PubMed Web of Science ®Google Scholar
• Wu S, Moomaw CR, Tomer KB, Falck JR, Zeldin DC. 1996. Molecular cloning and expression of cyp2j2, a human cytochrome p450 arachidonic acid epoxygenase highly expressed in heart. J Biol Chem. 271(7):3460–3468.
   PubMed Web of Science ®Google Scholar
• Xu X, Zhao CX, Wang L, Tu L, Fang X, Zheng C, Edin ML, Zeldin DC, Wang DW. 2010. Increased cyp2j3 expression reduces insulin resistance in fructose-treated rats and db/db mice. Diabetes. 59(4):997–1005.
   PubMed Web of Science ®Google Scholar
• Xu YZ, Zhang X, Wang L, Zhang F, Qiu Q, Liu ML, Zhang GR, Wu XL. 2013. An increased circulating angiotensin ii concentration is associated with hypoadiponectinemia and postprandial hyperglycemia in men with nonalcoholic fatty liver disease. Intern Med. 52(8):855–861.
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Newman JW. 2009. Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive goto—kakizaki rats. Clin Sci. 1(I6):l0.
   Google Scholar
• Yan SF, Ramasamy R, Naka Y, Schmidt AM. 2003. Glycation, inflammation, and rage. Circ Res. 93(12):1159–1169.
   PubMed Web of Science ®Google Scholar
• Yoshida S, Hirai A, Tamura Y, Yoshida S. 1990. Possible involvement of arachidonic acid metabolites of cytochrome P450 monooxygenase pathway in vasopressin-stimulated glycogenolysis in isolated rat hepatocytes. Arch Biochem Biophys. 280(2):346–351.
   PubMed Web of Science ®Google Scholar
• Yousif MHM, Benter IF, Dunn KMJ, Dahly-Vernon AJ, Akhtar S, Roman RJ. 2009a. Role of 20-hydroxyeicosatetraenoic acid in altering vascular reactivity in diabetes. Auton Autacoid Pharmacol. 29(1-2):1–12.
   PubMedGoogle Scholar
• Yousif MHM, Benter IF, Roman RJ. 2009b. Cytochrome p450 metabolites of arachidonic acid play a role in the enhanced cardiac dysfunction in diabetic rats following ischaemic reperfusion injury. Auton Autacoid Pharmacol. 29(1-2):33–41.
   PubMedGoogle Scholar
• Zeldin DC, Foley J, Boyle JE, Moomaw CR, Tomer KB, Parker C, Steenbergen C, Wu S. 1997. Predominant expression of an arachidonate epoxygenase in islets of langerhans cells in human and rat pancreas. Endocrinology. 138(3):1338–1346.
   PubMed Web of Science ®Google Scholar
• Zhang C, Booz GW, Yu Q, He X, Wang S, Fan F. 2018. Conflicting roles of 20-hete in hypertension and renal end organ damage. Eur J Pharmacol. 833:190–200.
   PubMed Web of Science ®Google Scholar
• Zhao CX, Xu X, Cui Y, Wang P, Wei X, Yang S, Edin ML, Zeldin DC, Wang DW. 2009. Increased endothelial nitric-oxide synthase expression reduces hypertension and hyperinsulinemia in fructose-treated rats. J Pharmacol Exp Ther. 328(2):610–620.
   PubMed Web of Science ®Google Scholar
• Zhu N, Huang B, Zhu L, Wang Y. 2021. Potential mechanisms of triptolide against diabetic cardiomyopathy based on network pharmacology analysis and molecular docking. J Diabetes Res. 2021:9944589.
   PubMed Web of Science ®Google Scholar